Adocia
ADOC.PADrugs in Pipeline
6
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
BioChaperone PDGF-BB
Diabetic Foot Ulcer
M1 Pram P037
Type 1 Diabetes Mellitus
BioChaperone insulin lispro 0.2U/Kg
Diabetes Mellitus Type 1
BioChaperone human insulin
Diabetes Mellitus Type 1
ADO09 formulation
Type 1 Diabetes Mellitus
BioChaperone Human Insulin (HinsBet®)
Type 1 Diabetes Mellitus
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BioChaperone PDGF-BB | Phase 3 | Diabetic Foot Ulcer | - | - |
M1 Pram P037 | Phase 2 | Type 1 Diabetes Mellitus | - | - |
BioChaperone insulin lispro 0.2U/Kg | Phase 2 | Diabetes Mellitus Type 1 | - | - |
BioChaperone human insulin | Phase 2 | Diabetes Mellitus Type 1 | - | - |
ADO09 formulation | Phase 2 | Type 1 Diabetes Mellitus | - | - |
BioChaperone Human Insulin (HinsBet®) | Phase 2 | Type 1 Diabetes Mellitus | - | - |
Frequently asked questions
What is in Adocia's drug pipeline?→
CatalystAlert tracks 6 drug candidates in Adocia's (ADOC.PA) pipeline across Phase 3, Phase 2. Its lead program is BioChaperone PDGF-BB (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Adocia's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Adocia (ADOC.PA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ADOC.PA biotech catalysts?→
Add ADOC.PA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Adocia's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.